[Kwe-101] | Executive Director Patient Safety Biopharma

At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. If you are swift to action, confident to lead, willing to collaborate, and curious about what science can do, then you're our kind of person.Patient Safety at AstraZeneca is now looking for an Executive Director Major Program Patient Safety BioPharma to join our team in Gothenburg, Sweden. The core purpose of AstraZeneca Patient Safety is to add value to AstraZeneca products, provide clear science-based guidance for investigators and prescribers to safeguard patients as well as the success of our business. Patient Safety covers the entire clinical life cycle of a drug from first time into man to withdrawal of a product from the market.What you'll doThe Executive Director position is a global role providing strategic PS input for TA and/or Disease Areas and quality and compliance oversight to a family of drug development and post-marketing programs across the life-cycle of substances and products. This includes dTPPs, patient populations, scientific understanding of toxicity-related mechanisms, risk management commitments, risk mitigation and communication.In this position, you will manage a global team of Global Safety Physicians and Strategic Safety Management Team Leaders, in order to support major PS programs and key initiatives.Your main accountabilities / responsibilitiesDrive staff development in support of AZ products.Ensure that own work and work of team is compliant with Good Clinical and Pharmacovigilance Practice, Safety Health and Environment (SHE) standards and all other relevant internal and external regulations and standards.Use expertise and knowledge of global issues to recruit and develop strategic Physicians and Scientists objectives for inclusion into business objectives.Provide TA Disease Area strategic PS input to a family of drug development and post-marketing programs across the life-cycle of substances and products.Be accountable at Portfolio-level for quality including review of key deliverables (e.g. RMPs and PSRs), and adherence to PV regulations.
#J-18808-Ljbffr